Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...
Autoimmune diseases arise when the immune system mistakenly targets and damages the body’s cells and tissues as though they ...
Secondary lymphedema, a chronic condition caused by lymph node removal during cancer surgery, leads to swelling, pain, and ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...
The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...
Objectives Understanding the molecular changes in the preclinical synovium is crucial for identifying factors that drive ...
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer ...
Findings from the Living Brain Project reveal how senescence processes involved in early brain development may also shape brain aging ...
Nestled in the Pegasus Park complex in Dallas, a globally recognized center for life science innovation, business and social ...
In an interview with Targeted Oncology, George Mulligan, PhD, discussed the key takeaways from analysis of the Immune Atlas ...
Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results